Moderate to severe plaque psoriasis clinical and n..

Yeni bir makale oluşturdu

6 gün

Moderate to severe plaque psoriasis clinical and non-clinical studies, key players, treatment evaluation, emerging therapies, treatment algorithms, pipeline analysis | Bristol-Myers Squibb, Akeso Biopharma, Jiangsu Hengrui Pharmaceutical | #health

Moderate to severe plaque psoriasis clinical and non-clinical studies, key players, treatment evaluation, emerging thera

Moderate to severe plaque psoriasis companies include Nimbus Therapeutics, Sun Pharmaceutical Industries Limited, Suzhou Zelgen Biopharmaceuticals, GC Cell Corporation, Bioeq GmbH, Dong-A ST Co., Ltd., Can-fite Biopharma, Bio-thera Solutions, AbbVie, Sinocelltech, Janssen Research and Deve

Beğen

Yorum yap

Paylaş

6 gün

Moderate to severe plaque psoriasis clinical and non-clinical studies, key players, treatment evaluation, emerging thera

Dil